A patient has a mutation in eIF2 that prevents GTP binding. Which process is primarily affected?
Category: Uncategorized
A patient has β-thalassemia due to abnormal RNA splicing. Wh…
A patient has β-thalassemia due to abnormal RNA splicing. What is the most likely molecular defect?
A patient with uncontrolled diabetes presents with fruity br…
A patient with uncontrolled diabetes presents with fruity breath and rapid breathing. Which metabolic process is primarily responsible?
A child with a mutation in the promoter of a gene has reduce…
A child with a mutation in the promoter of a gene has reduced protein levels. Which molecular event is primarily decreased?
A drug activates the Hippo pathway in epithelial cells. Whic…
A drug activates the Hippo pathway in epithelial cells. Which downstream effect is expected?
A tumor suppressor gene has a single base substitution resul…
A tumor suppressor gene has a single base substitution resulting in one amino acid change. Which mutation type is this?
A DNA-damaging agent activates CHK1 signaling. Which protein…
A DNA-damaging agent activates CHK1 signaling. Which protein is most likely degraded to pause S phase?
A mutation in a transcription factor reduces its DNA-binding…
A mutation in a transcription factor reduces its DNA-binding ability. Which molecular event is primarily decreased?
A researcher blocks release factor activity in bacteria. Wha…
A researcher blocks release factor activity in bacteria. What is the most likely result?
A researcher blocks polyadenylation of mRNA. Which effect is…
A researcher blocks polyadenylation of mRNA. Which effect is most likely?